Evidence map›Paper›PMID 38139148›Full record

ArticleInternational journal of molecular sciences2023

Takeshi Moriishi, Yosuke Kawai, Ryo Fukuyama, Yuki Matsuo, You-Wen He, Haruhiko Akiyama, Izumi Asahina, Toshihisa Komori

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Takeshi MoriishiDepartment of Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Japan.
Yosuke KawaiDepartment of Regenerative Oral Surgery, Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Japan.
Ryo FukuyamaLaboratory of Pharmacology, Hiroshima International University, Kure 737-0112, Japan.
Yuki MatsuoDepartment of Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Japan.
You-Wen HeDepartment of Immunology, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-8983-2684
Haruhiko AkiyamaDepartment of Orthopedic Surgery, Graduate School of Medicine, Gifu University, Gifu 501-1194, Japan.ORCID 0000-0002-5661-9895
Izumi AsahinaDepartment of Oral and Maxillofacial Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8431, Japan.ORCID 0000-0001-9448-2001
Toshihisa KomoriDepartment of Molecular Bone Biology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Japan.
Nagasaki University · JPDuke Medical Center · USGifu University · JPHiroshima International University · JPJuntendo University · JP

Funding

Japanese Ministry of Education, Culture, Sports, Science and Technology 15K10482, 25893182, 23H00440
6 · The paper itself

Abstract

Bcl2l1 (Bcl-XL) belongs to the Bcl-2 family, Bcl2 and Bcl2-XL are major anti-apoptotic proteins, and the apoptosis of osteoblasts is a key event for bone homeostasis. As the functions of Bcl2l1 in osteoblasts and bone homeostasis remain unclear, we generated osteoblast-specific

Indexed as

Bone ResorptionOsteogenesisAdenosine TriphosphateAnimalsApoptosisbcl-X ProteinCancellous BoneCell DifferentiationFemaleMaleMiceOsteoblastsOsteoclastsProto-Oncogene Proteins c-bcl-2Adenosine TriphosphateBcl2l1 protein, mousebcl-X ProteinProto-Oncogene Proteins c-bcl-2apoptosisATPBcl2l1Bcl-XLbone resorptionosteoblastosteoclastTnfsf11

Identifiers

PMID38139148
PMCPMC10743571
OpenAlexW4389566493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.